Testing effectiveness (Phase 2)Study completedNCT03058289
What this trial is testing
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
Who this might be right for
Breast CancerHead and Neck CancerSquamous Cell Carcinoma+8 more
Intensity Therapeutics, Inc. 111